This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Rx
CRYSVITA
10 mg, Roztwór do wstrzykiwań
INN: Burosumabum
Data updated: 2026-04-13
Available in:
🇨🇿🇩🇪🇬🇧🇪🇸🇫🇷🇵🇱🇵🇹🇸🇰🇺🇦
Form
Roztwór do wstrzykiwań
Dosage
10 mg
Route
podskórnie
Storage
CRYSVITA vials must be stored in the original carton until the time of use under refrigerated conditions at 36°F to 46°F (2°C to 8°C). Keep CRYSVITA vial in the original carton to protect from light until time of use. Do not freeze or shake CRYSVITA. Do not use CRYSVITA beyond the expiration date stamped on the carton. CRYSVITA vials are single-dose only. Discard any unused product.
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
About This Product
Manufacturer
Kyowa Kirin Holdings B.V. (Niemcy)
Composition
Burosumabum 10 mg
ATC Code
M05BX05
Source
URPL
11 DESCRIPTION Burosumab-twza is a human immunoglobulin G subclass 1 (IgG1), anti-human fibroblast growth factor 23 (FGF23) antibody produced by recombinant DNA technology using Chinese hamster ovary cells. Burosumab-twza is composed of two heavy chain (γ1-chain) molecules and two light chain (κ-chain) molecules. Each heavy chain has an N-linked carbohydrate moiety at asparagine 297 (Asn297). The molecular weight of burosumab-twza determined by mass spectrometry is approximately 147,000. CRYSVITA (burosumab-twza) injection for subcutaneous administration is supplied as a sterile, preservative-free, clear to slightly opalescent and colorless to pale brown-yellow solution in a single-dose vial. Each 1 mL of solution contains 10 mg, 20 mg or 30 mg of burosumab-twza, L-histidine (1.55 mg), L-methionine (1.49 mg), polysorbate 80 (0.5 mg), D-sorbitol (45.91 mg) in Water for Injection, USP. Hydrochloric acid may be used to adjust to a pH of 6.25.
⚠️ Warnings
Each vial is for single use only.
Do not shake the vial before use.
Burosumab should be administered using aseptic technique and sterile disposable syringes and injection needles.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.